Metastatic Breast Cancer Network
Metastatic Breast Cancer Network is a volunteer, patient-led 501(c)(3) nonprofit founded in 2004 that provides free education, peer support, clinical trial navigation, and the MBC Connect patient registry for the estimated 155,000 U.S. individuals living with Stage IV breast cancer and their caregivers.
- Company typePrivate
- Founded2004
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Metastatic Breast Cancer Network does
Metastatic Breast Cancer Network (MBCN) is a volunteer, patient-led 501(c)(3) nonprofit advocacy organization founded in 2004 and headquartered in New York (c/o SHARE, 165 West 46th St., Suite 712). It is the first organization solely devoted to the needs of patients with metastatic (Stage IV) breast cancer, serving an estimated 155,000 U.S. individuals living with MBC along with their caregivers and families. MBCN's mission centers on reducing isolation, providing disease-specific education, advocating for research funding, and amplifying the patient voice in policy and clinical trial design.
The organization delivers a portfolio of free patient resources: the MBC Connect mobile and web-based interactive patient registry and research portal (HIPAA-compliant, English/Spanish); the Metastatic Trial Search clinical trial finder powered by BreastCancerTrials.org; downloadable educational brochures; a peer-support telephone hotline and telephone support groups; online message boards; an e-newsletter; and patient-advocacy toolkits. MBC Connect enables patients to maintain longitudinal treatment profiles, complete quality-of-life surveys, and receive personalized news and clinical trial matches, building a de-identified dataset that supports MBC research. The organization also organizes and sponsors regional conferences and webinars.
MBCN operates on a donation- and sponsorship-based revenue model with no fees charged to patients or caregivers. Funding sources include individual and memorial donations, corporate sponsorships from pharmaceutical companies (notably Novartis's Kiss This 4 MBC campaign) and grants. Strategic alliances are central to its model: MBCN is a core member of the Metastatic Breast Cancer Alliance (32 nonprofits, 11 pharma/biotech firms, 18 patient advocates), collaborates with academic centers (UNC Lineberger, University of Pittsburgh Cancer Institute), Komen affiliates, METAvivor, and BreastCancerTrials.org, and played a leading role in establishing October 13 as National Metastatic Breast Cancer Awareness Day via U.S. Congressional resolutions in 2009.
Metastatic Breast Cancer Network firmographics
Firmographics- Name
- Metastatic Breast Cancer Network
- Legal name
- Metastatic Breast Cancer Network
- Website
- https://mbcn.org
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Metastatic Breast Cancer Network is a volunteer, patient-led 501(c)(3) nonprofit founded in 2004 that provides free education, peer support, clinical trial navigation, and the MBC Connect patient registry for the estimated 155,000 U.S. individuals living with Stage IV breast cancer and their caregivers.
- Ownership category
- akta.pro rank
Metastatic Breast Cancer Network industry classification
Industry- Product category
- Nonprofit Patient Advocacy Services
- NAICS
- Social Advocacy Organizations (8133), Voluntary Health Organizations (813212), Other Individual and Family Services (624190), Individual and Family Services (6241)
- SIC
- Services-Social Services (8300), Services-Health Services (8000), Services-Membership Organizations (8600)
- akta.pro primary industry
- Rare Disease & Special Needs Support Organizations (BPAGACAM)
Keywords
Where Metastatic Breast Cancer Network is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Metastatic Breast Cancer Network business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others
Revenue model
- Donations and Memorial Contributions: MBCN receives contributions made in memory of patients whose lives were cut short by metastatic breast cancer to fund research leadership awards and operational activities.
- Corporate Sponsorships: Partnerships with pharmaceutical companies like Novartis for campaigns such as Kiss This 4 MBC generate donations to fund metastatic breast cancer research.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free patient resources and tools |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels7 records
Metastatic Breast Cancer Network product offering
Product offeringCore offering
MBCN is a volunteer, patient-led advocacy organization that provides free information, education, peer support, and digital tools for people living with metastatic (Stage IV) breast cancer and their caregivers. Core offerings include the MBC Connect interactive patient registry, the Metastatic Trial Search clinical trial finder, free downloadable educational brochures, peer support hotlines and telephone support groups, online communities, advocacy resources, and sponsored educational conferences.
Product overview
Metastatic Breast Cancer Network (MBCN) is a volunteer, patient-led advocacy organization that provides information, resources, and support for people living with metastatic (Stage IV) breast cancer. The organization operates primarily as an information and support hub rather than a technology company. Its core offerings include MBC Connect, an interactive patient registry and research tool; the Metastatic Trial Search clinical trial finder; free educational brochures; peer support via telephone hotline and support groups; online communities; and patient advocacy resources. MBCN also organizes and sponsors conferences and educational events, and champions clinical trials and research funding for metastatic breast cancer.
Differentiator
Problem solved
Functional benefit
Products and services
- MBC Connect
- Metastatic Trial Search
- Clinical Trials Finder
- Free Brochures
Quantifiable outcome
- MBC Connect provides patients opportunity to own and update their own health information while analyzing aggregated patient data
- +1 more outcomes
Companies that use Metastatic Breast Cancer Network
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles1 record
Metastatic Breast Cancer Network technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Metastatic Breast Cancer Network partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, major and minor.
- Metastatic Breast Cancer AlliancecoreMBC Alliance is a consortium of 32 nonprofit organizations, 11 pharmaceutical/biotech companies, and 18 individual patient advocates. MBCN participates in the alliance which works to transform and improve lives of people living with MBC through advancing research, improving patient knowledge, and increasing public understanding of MBC. MBC Connect was launched by the Alliance.
- Metastatic Breast Cancer Connect RegistrycoreInteractive patient registry and research portal that provides patients ability to update information over time, respond to surveys about their MBC history and quality of life, and receive personalized clinical trial opportunities. Data is de-identified, encrypted, and HIPAA-compliant.
- University of North Carolina Lineberger Comprehensive Cancer CentermajorMBCN partnered with UNC Lineberger researchers for a national survey of 1,054 women with metastatic breast cancer on financial toxicity. MBCN helped recruit participants and offered a $10 Amazon gift card for survey completion.
- Susan G. Komen Greater NYCmajorMBCN partnered with Susan G. Komen Greater NYC as an association partner for the Truth and Dare Metastatic Breast Cancer Conference, providing learning, fellowship, and current information on MBC treatments and research.
- Susan G. Komen Puget SoundmajorMBCN participated as a sponsor and partner in the Northwest Metastatic Breast Cancer Conference supported by Komen Puget Sound, Amazon Web Services, Swedish Cancer Institute, and other sponsors.
- NovartismajorNovartis partnered with MBCN and METAvivor for the Kiss This 4 MBC campaign. For every social media post using #KissThis4MBC, Novartis donated $10 to MBCN and METAvivor, with a goal of generating at least $200,000 for metastatic breast cancer research.
- METAvivormajorMBCN partners with METAvivor for advocacy campaigns including Kiss This 4 MBC. Both are patient-driven advocacy organizations dedicated to supporting research for people living with metastatic breast cancer.
- University of Pittsburgh Cancer InstitutemajorMBCN awarded Dr. Steffi Oesterreich a $100,000 Research Leadership Award to support her research on invasive lobular breast cancer as a distinct subtype of metastatic breast cancer.
- BreastCancerTrials.orgcoreMetastatic Breast Cancer Alliance partnered with BreastCancerTrials.org to create the Metastatic Trial Search engine that translates clinical trial descriptions into plain English for easier patient access.
- SHARE Cancer SupportminorMBCN is hosted at SHARE's New York office location. SHARE is a cancer support organization providing resources for breast and ovarian cancer patients.
Scale indicators5 records
Recent moves6 records
Expansion highlights3 records
Metastatic Breast Cancer Network competitors and assessment
Company assessmentBroad incumbents
- American Cancer Society: Largest U.S. cancer nonprofit providing research funding, patient support, and education across all cancer types, including a dedicated MBC program. Overlaps with MBCN in patient education and research funding but operates at vastly larger scale across all cancers.
- Susan G. Komen: Largest U.S. breast cancer nonprofit, with significant MBC programming and regional affiliates (e.g., Komen Greater NYC, Komen Puget Sound) that partner with MBCN. Operates in the same patient space but with vastly greater fundraising, marketing, and grantmaking scale.
Direct peers
- SHARE Cancer Support: Cancer support organization for breast and ovarian cancer patients that hosts MBCN at its New York office. Provides peer support, helplines, and educational programs that closely mirror MBCN's offerings and patient segments.
- Breastcancer.org: Major nonprofit providing medically reviewed breast cancer information, community forums, and clinical trial resources. Highly comparable as a free digital education and peer community destination for breast cancer patients, including those with metastatic disease.
- Young Survival Coalition (YSC): Nonprofit supporting young adults diagnosed with breast cancer through resources, advocacy, and community. Comparable as a peer-support and education nonprofit targeting a defined breast cancer sub-population, though focused on age rather than stage.
- Tigerlily Foundation: Breast cancer advocacy organization focused on young women, with strong emphasis on MBC patients of color and patient-led programs. Comparable as a younger, patient-led advocacy nonprofit with similar education, support, and policy missions.
- METAvivor: Patient-driven metastatic breast cancer advocacy nonprofit that funds research grants and runs MBC awareness campaigns. METAvivor is the most directly comparable peer — co-partner with MBCN on Kiss This 4 MBC and shares the same mission, donor base, and patient-led model.
- National Breast Cancer Coalition (NBCC): Advocacy-focused breast cancer nonprofit that lobbies for research funding and policy change. Comparable to MBCN as a policy-driven advocacy voice for breast cancer patients, though broader in scope.
- Living Beyond Breast Cancer (LBBC): National nonprofit providing education and support to people affected by breast cancer, including a dedicated metastatic program. Comparable as a peer-led education and support organization with overlapping patient resources, conferences, and helpline services.
Others
- Metastatic Breast Cancer Alliance: Coalition of 60+ nonprofits, pharma companies, and patient advocates — of which MBCN is a founding member — that coordinates cross-organization MBC research and advocacy. Treated as an ecosystem/parent-like entity rather than a direct competitor.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Metastatic Breast Cancer Network social profiles
Digital presenceMetastatic Breast Cancer Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metastatic Breast Cancer Network leadership team
Management profileNumber of profiles
Profiles3 records
Metastatic Breast Cancer Network funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metastatic Breast Cancer Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metastatic Breast Cancer Network
What does Metastatic Breast Cancer Network do?
MBCN is a volunteer, patient-led advocacy organization that provides free information, education, peer support, and digital tools for people living with metastatic (Stage IV) breast cancer and their caregivers. Core offerings include the MBC Connect interactive patient registry, the Metastatic Trial Search clinical trial finder, free downloadable educational brochures, peer support hotlines and telephone support groups, online communities, advocacy resources, and sponsored educational conferences.
Is Metastatic Breast Cancer Network a public or private company?
Metastatic Breast Cancer Network is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Metastatic Breast Cancer Network founded?
Metastatic Breast Cancer Network was founded in 2004. It employs 1 to 10 people.
Where is Metastatic Breast Cancer Network based?
Metastatic Breast Cancer Network is headquartered in New York, United States, in the North America region.
How does Metastatic Breast Cancer Network make money?
Two revenue lines are on record. Donations and Memorial Contributions are the primary driver. The others are corporate Sponsorships.
Who are Metastatic Breast Cancer Network's main competitors?
Broad incumbents on record are American Cancer Society and Susan G. Komen. Direct peers are SHARE Cancer Support, Breastcancer.org, Young Survival Coalition (YSC), Tigerlily Foundation, METAvivor, National Breast Cancer Coalition (NBCC) and Living Beyond Breast Cancer (LBBC). Metastatic Breast Cancer Alliance is listed as an others.
Does Metastatic Breast Cancer Network have an API?
No public API is recorded for Metastatic Breast Cancer Network.
What industry is Metastatic Breast Cancer Network in?
Metastatic Breast Cancer Network's product category is Nonprofit Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations. Its NAICS code is 8133 and its SIC code is 8300.